Microwave Ablation of An Autonomous Functioning Thyroid Nodule in A Pregnant Patient: A Case Report

doi:10.37015/AUDT.2019.190824

Abstract

Abstract:

An autonomous functioning thyroid nodule (AFTN) is a benign disease. It can autonomously secrete excessive thyroid hormones without the need for TSH stimulation. It is not subject to the hypothalamic-pituitary-thyroid axis and is rare during pregnancy. Here we report a case of a 36-year-old pregnant woman with hyperthyroidism detected in early pregnancy, According to ultrasound and laboratory results, she was diagnosed with an AFTN. Ultrasound-guided (US-guided) microwave ablation (MWA) was used to treat AFTN during the second trimester of pregnancy. Hyperthyroidism crisis and other complications did not occur due to MWA. Thyroid function was normal at 2, 3 and 4 months after MWA. The volume reduction rate (VRR) was 83.67% at 4 months after MWA. The patient gave birth normally at 40 weeks gestation. All indices of thyroid function were normal during postpartum and lactation. US-guided MWA is a feasible and safe method for the treatment of AFTN during pregnancy, specifically in the second trimester.

Key words: Microwave ablation; Autonomous functioning thyroid nodule; Pregnancy; Thyroid function

Shengnan Huo, MD, Lin Yin, Lili Peng, MD, Zhao Wang, MD, Ming-an Yu, MD. Microwave Ablation of An Autonomous Functioning Thyroid Nodule in A Pregnant Patient: A Case Report. Advanced Ultrasound in Diagnosis and Therapy, 2019, 3(3): 136-139.

References

[1]	Springer D, Jiskra J, Limanova Z, Zima T, Potlukova E. Thyroid in pregnancy: From physiology to screening. Crit Rev Clin Lab Sci 2017; 54:102-16.
[2]	King JR, Lachica R, Lee RH, Montoro M, Mestman J. Diagnosis and Management of Hyperthyroidism in Pregnancy: A Review. Obstet Gynecol Surv 2016; 71:675-85.
[3]	Kohlhase KD, Korkusuz Y, Gr?ner D, Erbelding C, Happel C, Luboldt W, et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperthermia 2016; 32:511-6.
[4]	Zhang M, Luo Y, Zhang Y, Tang J. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid 2016; 26:1581-7.
[5]	Feng B, Liang P, Cheng Z, Yu X, Yu J, Han Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol 2012; 166:1031-7.
[6]	Cheng SP, Liu CL. Preoperative ultrasonography assessment of vocal cord movement during thyroid and parathyroid surgery: reply. World J Surg 2013; 37:1741-2.
[7]	Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid 2013; 23:1578-82.
[8]	Y Wang , LY Gao, YX Jiang, H Pan, J Zhao, X Zhou,et al. Image features-based learning effectively improves inter-observer agreement for beginners in evaluating thyroid nodule with ultrasound. AUDT 2019; 01:1-5.
[9]	Bestwick JP, John R, Maina A, Guaraldo V, Joomun M, Wald NJ, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs). Clin Chim Acta 2014; 430:33-7.
[10]	Calegaro JU, De Freitas Gomes E, Bae SH, Ulyssea R, Casulari LA. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.Panminerva Med 2000; 42:241-5.
[11]	Lee ES, Kim JH, Na DG, Paeng JC, Min HS, Choi SH, et al. Hyperfunction thyroid nodules: their risk for becoming or being associated with thyroid cancers. Korean J Radiol 2013; 14:643-52.
[12]	Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, et al. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid 2014; 24:1027-31.
[13]	Dudea SM, Botar-Jid C. Ultrasound elastography in thyroid disease. Med Ultrason 2015; 17:74-96.
[14]	Auharek SA, de Fran?a LR. Postnatal testis development, Sertoli cell proliferation and number of different spermatogonial types in C57BL/6J mice made transiently hypo- and hyperthyroidic during the neonatal period. J Anat 2010; 216:577-88.
[15]	Korevaar TI, Nieboer D, Bisschop PH, Goddijn M, Medici M, Chaker L, et al. Risk factors and a clinical prediction model for low maternal thyroid function during early pregnancy: two population-based prospective cohort studies. Clin Endocrinol (Oxf) 2016; 85:902-9.
[16]	Xu C, Li L, Xu W, Du C, Yang L, Tong J, et al. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results. Int J Hyperthermia 2019; 36:351-8.
[17]	Nomoto H, Kameda H, Nakamura A, Tsuchida K, Nagai S, Atsumi T, et al. Breakdown of autonomously functioning thyroid nodule accompanied by acromegaly after octreotide treatment. Front Endocrinol (Lausanne) 2019; 10:131.
[18]	Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN, et al. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Invest 2014; 77:94-9.
[19]	Andersen SL, Laurberg P, Wu CS, Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG 2014; 121:1365-74.